Policy & Regulation
Vivera Pharmaceuticals names senior technology advisor and interim chief technology officer
1 July 2022 -

Vivera Pharmaceuticals, a US-based pharmaceutical company, announced on Thursday that it has added Guido Jouret, PhD to the company's board of advisors as senior technology advisor and interim chief technology officer.

Dr Jouret has over 25 years of leadership experience across various technology sectors, such as software, services, networking, cloud platforms, and hardware. He has served as chief digital officer of ABB. Prior to ABB, Dr Jouret was with Cisco Systems, Inc., where he spent seven years in its Emerging Technologies Group. He has served as general manager of Cisco, president of Digital Platforms for Envision Energy, chief technology officer at Nokia Technologies, several executive-level roles for notable companies, including chief development officer for Plume.

Paul Edalat, Vivera chairman and CEO, said, 'Dr Jouret has an impressive track record for leading and developing technology-centric businesses. Vivera is looking forward to utilising Dr Jouret's expertise as the company moves past the engineering stage of ZICOH (Vivera's patented, high-tech, dose-controlled, electronic prescription delivery device) and begins to develop the hardware and software for the device and begins to lay the framework for the overall commercialisation strategy.'

Login
Username:

Password: